Skin-cap (Skin-cap)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceZinc pyrithioneZinc pyrithione
Similar drugsTo uncover
  • Skin-cap
    shampoo externally 
    INVAR, LLC     Russia
  • Skin-cap
    cream externally 
    INVAR, LLC     Russia
  • Skin-cap
    aerosol externally 
    INVAR, LLC     Russia
  • Zinocap®
    cream externally 
    Otisipharm, PAO    
  • Zinocap®
    aerosol externally 
    Otisipharm, PAO    
    • Dosage form: & nbspCream for external use.
    Composition:

    100 g of the preparation contain:

    Active substance: pyrithione zinc activated 200 mg

    Excipients: glyceride mono- and distearate (Tegin M) caprylic caprylate (Tegosoft EE), methyldextrose and macrogol-20 ether (Tegosoft E20), isopropyl palmitate (TegoSoft R), methyldextrose polyglyceryl distearate (Tego Car 450), butylhydroxytoluene, glycerol, propyl parahydroxybenzoate (Tegosoft LCE 65K), stearyl alcohol (Tego Alkanol 18), ethanol, flavoring (citronellol, phenylethanol, geraniol, terpineol, cinnamyl alcohol), cyclomethicone (Abil K 4), water.

    Description:

    The cream is white with a characteristic smell.

    Pharmacotherapeutic group:Dermatoprotective agent.
    ATX: & nbsp

    D.11.A.X.12   Zinc pyrithione

    Pharmacodynamics:

    Zinc pyrithione activated has anti-inflammatory, antibacterial and antifungal activity. Antifungal activity is particularly pronounced in relation to Pityrosporum ovale and Pityrosporum orbiculare, which support inflammation and excessive desquamation in dandruff, seborrhea, psoriasis and other skin diseases.Zinc pyrithione reduces the intracellular level of ATP, promotes depolarization of cell membranes and death of fungi and bacteria.

    Pharmacokinetics:

    With external use, zinc pyrithione activated is deposited in the epidermis and superficial layers of the dermis. Systemic absorption is slow. The drug is found in the blood in trace amounts.

    Indications:Psoriasis, atopic dermatitis, eczema, neurodermatitis, dry skin, seborrheic dermatitis in adults and children from 1 year.
    Contraindications:

    Hypersensitivity to the components of the drug.

    Dosing and Administration:

    Outwardly. After intensive shaking, the cream is applied a thin layer on the affected skin areas 2 times a day. The course of treatment for psoriasis 1-1,5 months, with atopic dermatitis 3-4 weeks.

    Dosing and Administration in Pediatrics: the way of application and dose in children do not differ from the method of application and doses in adults.

    If necessary, you can repeat the course of treatment after 1-1,5 months after consulting a doctor.

    Side effects:

    Allergic reactions.

    In the first days of treatment, there may be a brief burning sensation at the site of application, which, as a rule, does not require the drug to be withdrawn.

    Interaction:

    Clinically significant interaction of the drug Skin-cap with other drugs has not been identified.

    Form release / dosage:Cream for external use 0,2%.
    Packaging:

    5 grams in a sachet of laminated foil. For 15 g and 50 g in a plastic tube. Each tube together with instructions for medical use is placed in a cardboard box.

    Storage conditions:

    At temperatures from +4 to +20 ° C, out of reach of children.

    Shelf life:

    3 years. Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N012231 / 02
    Date of registration:07.07.2008
    The owner of the registration certificate:INVAR, LLC INVAR, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.10.2015
    Illustrated instructions
      Instructions
      Up